The Market Reports

Index

1 Tuberculosis Prevention and Treatment Vaccine Market Overview
1.1 Product Overview and Scope of Tuberculosis Prevention and Treatment Vaccine
1.2 Tuberculosis Prevention and Treatment Vaccine Segment by Type
1.2.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 Tuberculosis Prevention and Treatment Vaccine Segment by Application
1.3.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Global Tuberculosis Prevention and Treatment Vaccine Market Size Estimates and Forecasts
1.4.1 Global Tuberculosis Prevention and Treatment Vaccine Revenue 2016-2027
1.4.2 Global Tuberculosis Prevention and Treatment Vaccine Sales 2016-2027
1.4.3 Tuberculosis Prevention and Treatment Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Tuberculosis Prevention and Treatment Vaccine Market Competition by Manufacturers
2.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Tuberculosis Prevention and Treatment Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Tuberculosis Prevention and Treatment Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Tuberculosis Prevention and Treatment Vaccine Market Competitive Situation and Trends
2.5.1 Tuberculosis Prevention and Treatment Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Tuberculosis Prevention and Treatment Vaccine Players Market Share by Revenue
2.5.3 Global Tuberculosis Prevention and Treatment Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Tuberculosis Prevention and Treatment Vaccine Retrospective Market Scenario by Region
3.1 Global Tuberculosis Prevention and Treatment Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Tuberculosis Prevention and Treatment Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Tuberculosis Prevention and Treatment Vaccine Market Facts & Figures by Country
3.3.1 North America Tuberculosis Prevention and Treatment Vaccine Sales by Country
3.3.2 North America Tuberculosis Prevention and Treatment Vaccine Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Tuberculosis Prevention and Treatment Vaccine Market Facts & Figures by Country
3.4.1 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country
3.4.2 Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Tuberculosis Prevention and Treatment Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Region
3.5.2 Asia Pacific Tuberculosis Prevention and Treatment Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Tuberculosis Prevention and Treatment Vaccine Market Facts & Figures by Country
3.6.1 Latin America Tuberculosis Prevention and Treatment Vaccine Sales by Country
3.6.2 Latin America Tuberculosis Prevention and Treatment Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Sales by Country
3.7.2 Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Tuberculosis Prevention and Treatment Vaccine Historic Market Analysis by Type
4.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2016-2021)

5 Global Tuberculosis Prevention and Treatment Vaccine Historic Market Analysis by Application
5.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Tuberculosis Prevention and Treatment Vaccine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Japan BCG Lab
6.2.1 Japan BCG Lab Corporation Information
6.2.2 Japan BCG Lab Description and Business Overview
6.2.3 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.2.5 Japan BCG Lab Recent Developments/Updates
6.3 Serum Institute of India
6.3.1 Serum Institute of India Corporation Information
6.3.2 Serum Institute of India Description and Business Overview
6.3.3 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.3.5 Serum Institute of India Recent Developments/Updates
6.4 AJ Vaccines
6.4.1 AJ Vaccines Corporation Information
6.4.2 AJ Vaccines Description and Business Overview
6.4.3 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.4.5 AJ Vaccines Recent Developments/Updates
6.5 BioFarma
6.5.1 BioFarma Corporation Information
6.5.2 BioFarma Description and Business Overview
6.5.3 BioFarma Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 BioFarma Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.5.5 BioFarma Recent Developments/Updates
6.6 GreenSignal Bio Pharma
6.6.1 GreenSignal Bio Pharma Corporation Information
6.6.2 GreenSignal Bio Pharma Description and Business Overview
6.6.3 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.6.5 GreenSignal Bio Pharma Recent Developments/Updates
6.7 China National Biotec
6.6.1 China National Biotec Corporation Information
6.6.2 China National Biotec Description and Business Overview
6.6.3 China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.7.5 China National Biotec Recent Developments/Updates
6.8 Biomed Lublin
6.8.1 Biomed Lublin Corporation Information
6.8.2 Biomed Lublin Description and Business Overview
6.8.3 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.8.5 Biomed Lublin Recent Developments/Updates
6.9 Taj Pharmaceuticals
6.9.1 Taj Pharmaceuticals Corporation Information
6.9.2 Taj Pharmaceuticals Description and Business Overview
6.9.3 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.9.5 Taj Pharmaceuticals Recent Developments/Updates
6.10 Ataulpho de Paiva
6.10.1 Ataulpho de Paiva Corporation Information
6.10.2 Ataulpho de Paiva Description and Business Overview
6.10.3 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.10.5 Ataulpho de Paiva Recent Developments/Updates
6.11 IVAC
6.11.1 IVAC Corporation Information
6.11.2 IVAC Tuberculosis Prevention and Treatment Vaccine Description and Business Overview
6.11.3 IVAC Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 IVAC Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.11.5 IVAC Recent Developments/Updates
6.12 Queen Saovabha Mem. Inst
6.12.1 Queen Saovabha Mem. Inst Corporation Information
6.12.2 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Description and Business Overview
6.12.3 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
6.13 Microgen
6.13.1 Microgen Corporation Information
6.13.2 Microgen Tuberculosis Prevention and Treatment Vaccine Description and Business Overview
6.13.3 Microgen Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Microgen Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.13.5 Microgen Recent Developments/Updates

7 Tuberculosis Prevention and Treatment Vaccine Manufacturing Cost Analysis
7.1 Tuberculosis Prevention and Treatment Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Tuberculosis Prevention and Treatment Vaccine
7.4 Tuberculosis Prevention and Treatment Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Tuberculosis Prevention and Treatment Vaccine Distributors List
8.3 Tuberculosis Prevention and Treatment Vaccine Customers

9 Tuberculosis Prevention and Treatment Vaccine Market Dynamics
9.1 Tuberculosis Prevention and Treatment Vaccine Industry Trends
9.2 Tuberculosis Prevention and Treatment Vaccine Growth Drivers
9.3 Tuberculosis Prevention and Treatment Vaccine Market Challenges
9.4 Tuberculosis Prevention and Treatment Vaccine Market Restraints

10 Global Market Forecast
10.1 Tuberculosis Prevention and Treatment Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Tuberculosis Prevention and Treatment Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Tuberculosis Prevention and Treatment Vaccine by Type (2022-2027)
10.2 Tuberculosis Prevention and Treatment Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Tuberculosis Prevention and Treatment Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Tuberculosis Prevention and Treatment Vaccine by Application (2022-2027)
10.3 Tuberculosis Prevention and Treatment Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Tuberculosis Prevention and Treatment Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Tuberculosis Prevention and Treatment Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Tuberculosis Prevention and Treatment Vaccine Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Tuberculosis Prevention and Treatment Vaccine Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Tuberculosis Prevention and Treatment Vaccine Covered in This Study
Table 5. Global Tuberculosis Prevention and Treatment Vaccine Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Tuberculosis Prevention and Treatment Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Tuberculosis Prevention and Treatment Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Tuberculosis Prevention and Treatment Vaccine Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Tuberculosis Prevention and Treatment Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Tuberculosis Prevention and Treatment Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Tuberculosis Prevention and Treatment Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Prevention and Treatment Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Tuberculosis Prevention and Treatment Vaccine Sales by Region (2016-2021) & (K Units)
Table 16. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2016-2021) & (K Units)
Table 19. North America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2016-2021) & (K Units)
Table 23. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global Tuberculosis Prevention and Treatment Vaccine Sales (K Units) by Type (2016-2021)
Table 39. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global Tuberculosis Prevention and Treatment Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Tuberculosis Prevention and Treatment Vaccine Revenue Share by Type (2016-2021)
Table 42. Global Tuberculosis Prevention and Treatment Vaccine Price (US$/Unit) by Type (2016-2021)
Table 43. Global Tuberculosis Prevention and Treatment Vaccine Sales (K Units) by Application (2016-2021)
Table 44. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global Tuberculosis Prevention and Treatment Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Tuberculosis Prevention and Treatment Vaccine Revenue Share by Application (2016-2021)
Table 47. Global Tuberculosis Prevention and Treatment Vaccine Price (US$/Unit) by Application (2016-2021)
Table 48. Merck Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Merck Tuberculosis Prevention and Treatment Vaccine Product
Table 52. Merck Recent Developments/Updates
Table 53. Japan BCG Lab Corporation Information
Table 54. Japan BCG Lab Description and Business Overview
Table 55. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product
Table 57. Japan BCG Lab Recent Developments/Updates
Table 58. Serum Institute of India Corporation Information
Table 59. Serum Institute of India Description and Business Overview
Table 60. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product
Table 62. Serum Institute of India Recent Developments/Updates
Table 63. AJ Vaccines Corporation Information
Table 64. AJ Vaccines Description and Business Overview
Table 65. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product
Table 67. AJ Vaccines Recent Developments/Updates
Table 68. BioFarma Corporation Information
Table 69. BioFarma Description and Business Overview
Table 70. BioFarma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. BioFarma Tuberculosis Prevention and Treatment Vaccine Product
Table 72. BioFarma Recent Developments/Updates
Table 73. GreenSignal Bio Pharma Corporation Information
Table 74. GreenSignal Bio Pharma Description and Business Overview
Table 75. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product
Table 77. GreenSignal Bio Pharma Recent Developments/Updates
Table 78. China National Biotec Corporation Information
Table 79. China National Biotec Description and Business Overview
Table 80. China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. China National Biotec Tuberculosis Prevention and Treatment Vaccine Product
Table 82. China National Biotec Recent Developments/Updates
Table 83. Biomed Lublin Corporation Information
Table 84. Biomed Lublin Description and Business Overview
Table 85. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product
Table 87. Biomed Lublin Recent Developments/Updates
Table 88. Taj Pharmaceuticals Corporation Information
Table 89. Taj Pharmaceuticals Description and Business Overview
Table 90. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product
Table 92. Taj Pharmaceuticals Recent Developments/Updates
Table 93. Ataulpho de Paiva Corporation Information
Table 94. Ataulpho de Paiva Description and Business Overview
Table 95. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product
Table 97. Ataulpho de Paiva Recent Developments/Updates
Table 98. IVAC Corporation Information
Table 99. IVAC Description and Business Overview
Table 100. IVAC Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. IVAC Tuberculosis Prevention and Treatment Vaccine Product
Table 102. IVAC Recent Developments/Updates
Table 103. Queen Saovabha Mem. Inst Corporation Information
Table 104. Queen Saovabha Mem. Inst Description and Business Overview
Table 105. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product
Table 107. Queen Saovabha Mem. Inst Recent Developments/Updates
Table 108. Microgen Corporation Information
Table 109. Microgen Description and Business Overview
Table 110. Microgen Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Microgen Tuberculosis Prevention and Treatment Vaccine Product
Table 112. Microgen Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Tuberculosis Prevention and Treatment Vaccine Distributors List
Table 116. Tuberculosis Prevention and Treatment Vaccine Customers List
Table 117. Tuberculosis Prevention and Treatment Vaccine Market Trends
Table 118. Tuberculosis Prevention and Treatment Vaccine Growth Drivers
Table 119. Tuberculosis Prevention and Treatment Vaccine Market Challenges
Table 120. Tuberculosis Prevention and Treatment Vaccine Market Restraints
Table 121. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Type (2022-2027) & (K Units)
Table 122. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 123. Global Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 124. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 125. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Application (2022-2027) & (K Units)
Table 126. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 127. Global Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 128. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 129. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Region (2022-2027) & (K Units)
Table 130. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 131. Global Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 132. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tuberculosis Prevention and Treatment Vaccine
Figure 2. Global Tuberculosis Prevention and Treatment Vaccine Market Share by Type in 2020 & 2027
Figure 3. Immune Vaccine Product Picture
Figure 4. Therapy Vaccine Product Picture
Figure 5. Global Tuberculosis Prevention and Treatment Vaccine Market Share by Application in 2020 & 2027
Figure 6. Self-Procurement
Figure 7. UNICEF
Figure 8. Other
Figure 9. Global Tuberculosis Prevention and Treatment Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Tuberculosis Prevention and Treatment Vaccine Market Size 2016-2027 (US$ Million)
Figure 11. Global Tuberculosis Prevention and Treatment Vaccine Sales 2016-2027 (K Units)
Figure 12. Global Tuberculosis Prevention and Treatment Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Tuberculosis Prevention and Treatment Vaccine Sales Share by Manufacturers in 2020
Figure 14. Global Tuberculosis Prevention and Treatment Vaccine Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Tuberculosis Prevention and Treatment Vaccine Players: Market Share by Revenue in 2020
Figure 16. Tuberculosis Prevention and Treatment Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2016-2021)
Figure 18. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region in 2020
Figure 19. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Region (2016-2021)
Figure 20. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Region in 2020
Figure 21. United States Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Taiwan Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Mexico Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Brazil Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Argentina Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Turkey Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Saudi Arabia Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. UAE Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Sales Market Share of Tuberculosis Prevention and Treatment Vaccine by Type (2016-2021)
Figure 44. Sales Market Share of Tuberculosis Prevention and Treatment Vaccine by Application (2016-2021)
Figure 45. Sales Market Share of Tuberculosis Prevention and Treatment Vaccine by Application in 2020
Figure 46. Revenue Share of Tuberculosis Prevention and Treatment Vaccine by Application (2016-2021)
Figure 47. Revenue Share of Tuberculosis Prevention and Treatment Vaccine by Application in 2020
Figure 48. Manufacturing Cost Structure of Tuberculosis Prevention and Treatment Vaccine
Figure 49. Manufacturing Process Analysis of Tuberculosis Prevention and Treatment Vaccine
Figure 50. Tuberculosis Prevention and Treatment Vaccine Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed